Abstract | AIMS AND BACKGROUND: METHODS: A retrospective analysis of consecutive elderly (≥70 years of age) patients with advanced non-small cell lung cancer treated at our Medical Oncology Unit from February 2005 to September 2011 was performed. RESULTS: A total of 249 cycles of chemotherapy was administered to 62 patients (median age, 72 years; range, 70-81) presenting a median Charlson comorbidity index of 1 and a good ECOG PS (0-1, 52 patients; 2, 10 patients). The median number of cycles/patient was 4, and all 62 patients received a platinum-based doublet as first-line chemotherapy: 57 with carboplatin (92%) and 5 with cisplatin (8%). As best response to the treatment, 19 (31%) partial responses and 20 (32%) stable diseases were observed. Median overall survival was 9.8 months. Toxicity was mild; grade III-IV neutropenia was the most frequently observed side effect in 19 administered cycles (8%). CONCLUSIONS: Advanced non-small cell lung cancer in elderly patients can be safely treated with a platinum-based doublet. Observed toxicity is manageable, and overall survival is in keeping with data from the literature.
|
Authors | Paolo Piacentini, Filippo Greco, Anna Mercanti, Anna Rita Trolese, Emilia Durante, Giacomo Moratello, Michele Tognetto, Lara Furini, Jacopo Giuliani, Andrea Bonetti |
Journal | Tumori
(Tumori)
2013 Nov-Dec
Vol. 99
Issue 6
Pg. 650-5
ISSN: 2038-2529 [Electronic] United States |
PMID | 24503786
(Publication Type: Journal Article)
|
Chemical References |
- Deoxycytidine
- Vinblastine
- Carboplatin
- Cisplatin
- Vinorelbine
- Gemcitabine
|
Topics |
- Adenocarcinoma
(drug therapy)
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Carboplatin
(administration & dosage)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, pathology)
- Carcinoma, Squamous Cell
(drug therapy)
- Cisplatin
(administration & dosage)
- Comorbidity
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms
(drug therapy, pathology)
- Male
- Neoplasm Staging
- Retrospective Studies
- Treatment Outcome
- Vinblastine
(administration & dosage, analogs & derivatives)
- Vinorelbine
- Gemcitabine
|